These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27503344)

  • 1. Evaluating the carotid bodies and renal nerves as therapeutic targets for hypertension.
    McBryde FD; Hart EC; Ramchandra R; Paton JF
    Auton Neurosci; 2017 May; 204():126-130. PubMed ID: 27503344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
    Voora R; Hinderliter AL
    Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoring autonomic balance: future therapeutic targets.
    Sobotka PA; Osborn JW; Paton JF
    EuroIntervention; 2013 May; 9 Suppl R():R140-8. PubMed ID: 23732147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Carotid Body in an Ovine Model of Renovascular Hypertension.
    Chang JW; Tromp TR; Joles JA; McBryde FD; Paton JFR; Ramchandra R
    Hypertension; 2020 Nov; 76(5):1451-1460. PubMed ID: 32981362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device Therapy of Hypertension.
    Mahfoud F; Schlaich MP; Lobo MD
    Circ Res; 2021 Apr; 128(7):1080-1099. PubMed ID: 33793330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Previous exposure to chronic intermittent hypoxia blunts the development of one-kidney, one-clip hypertension in rats.
    Perim RR; Amorim MR; Bonagamba TLLGH; Machado BH
    Exp Physiol; 2018 Apr; 103(4):473-482. PubMed ID: 29359403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension.
    McBryde FD; Abdala AP; Hendy EB; Pijacka W; Marvar P; Moraes DJ; Sobotka PA; Paton JF
    Nat Commun; 2013; 4():2395. PubMed ID: 24002774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotid Body Ablation: a New Target to Address Central Autonomic Dysfunction.
    Iturriaga R
    Curr Hypertens Rep; 2018 May; 20(6):53. PubMed ID: 29789952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches in the treatment of hypertension.
    Oparil S; Schmieder RE
    Circ Res; 2015 Mar; 116(6):1074-95. PubMed ID: 25767291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiological basis of renal nerve ablation for the treatment of hypertension.
    Ziakas A; Gossios T; Doumas M; Karali K; Megarisiotou A; Stiliadis I
    Curr Vasc Pharmacol; 2014 Jan; 12(1):23-9. PubMed ID: 23905601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Renal Sympathetic Denervation on Arterial Stiffness and Blood Pressure Control in Resistant Hypertensive Patients: A Single Centre Prospective Study.
    Baroni M; Nava S; Giupponi L; Meani P; Panzeri F; Varrenti M; Maloberti A; Soriano F; Agrati AM; Ferraro G; Colombo F; Rampoldi A; Mancia G; Colombo P; Klugmann S; Giannattasio C
    High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):411-6. PubMed ID: 26458940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Device-Based Therapy for Drug-Resistant Hypertension: An Update.
    Li P; Nader M; Arunagiri K; Papademetriou V
    Curr Hypertens Rep; 2016 Aug; 18(8):64. PubMed ID: 27402013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal sympathetic denervation for treating resistant hypertension.
    Polimeni A; Curcio A; Indolfi C
    Circ J; 2013; 77(4):857-63. PubMed ID: 23514712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a Computational Model of Renal Nerves and Surgical System for Laparoscopic Renal Denervation.
    Ye E; Lee SH; Baik J; Ryu SY; Song WH; Choi EK; Jeong CW; Park SM
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():4524-4527. PubMed ID: 30441357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal sympathetic nerves - what have they got to do with cardiovascular disease?
    Barrett CJ
    Exp Physiol; 2015 Apr; 100(4):359-65. PubMed ID: 25643915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal sympathetic denervation: hypertension therapy and beyond.
    Williams PD; Whitbourn R
    Expert Rev Med Devices; 2013 May; 10(3):329-38. PubMed ID: 23668705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasticity of cardiovascular chemoreflexes after prolonged unilateral carotid body denervation: implications for its therapeutic use.
    Eugenín J; Larraín C; Zapata P
    Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1325-H1336. PubMed ID: 32330089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human carotid bodies as a therapeutic target: new insights from a clinician's perspective.
    Tubek S; Niewiński P; Paleczny B; Langner A; Banasiak W; Ponikowski P
    Kardiol Pol; 2018; 76(10):1426-1433. PubMed ID: 30251240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What we need to know about renal nerve ablation for treatment of hypertension and other states of sympathetic overactivity.
    Schlaich MP
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1267-F1270. PubMed ID: 27630063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Afferents.
    Frame AA; Carmichael CY; Wainford RD
    Curr Hypertens Rep; 2016 Sep; 18(9):69. PubMed ID: 27595156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.